Objective-To examine association of different measures of serum lipid concentration and obesity with mortality in women.
Introduction
It is generally assumed that people who are obese or hypercholesterolaemic are at greater risk of death from cardiovascular disease. Epidemiological studies, however, have not consistently supported this assumption. Some studies have suggested that the localisation rather than the degree of obesity is a risk factor for cardiovascular disease in women.'-3 Similarly, high triglyceride concentrations may pose a greater threat than hypercholesterolaemia in women. '9 Because some of these studies did not investigate the independent contributions of these four risk factors in the prediction of mortality and cardiovascular disease, we have re-examined this issue.
A cohort of women has been studied in Gothenburg, Sweden, since 1968 and has now been followed up for 20 years. We have related baseline risk factors to death from myocardial infarction and total mortality during follow up.
Subjects and methods

SUBJECTS
In 1968-9, 1462 women in Gothenburg, Sweden, who were aged 38, 46, 50, 54, or 60 were recruited to the study.10 The systematic sampling based on date of birth and the high rate of participation (90 1%) ensured that the recruits were a representative cross section of women from the community in the age groups studied. The cohort was re-examined in 1974-5" and in 1980-1.52 In 1980-1, 1154 women attended the examination and another 197 women were contacted by telephone or postal interview so that 1351 women gave information about history of myocardial infarction and stroke. Of those recruited in 1968-9, 1383 were known to be still alive in 1980-1 and vital status was ascertained in 1458 of them. '2 In 1988-9 (20 years after the initial study) we obtained updated information from the Swedish National Death Registry and, for surviving subjects, from the Swedish Person and Address Registry. By comparing these registers, we identified 1450 of the initial 1462 participants. We obtained copies of death certificates for all the deaths in this group and identified deaths from myocardial infarction as those in which the death certificate gave myocardial infarction as the principal cause of death. A postmortem examination was carried out in 68% of a subsample of 59 of these deaths, which is in accordance with the necropsy rate reported from Gothenburg." CLINICAL EXAMINATION In the initial study of 1968-9 blood samples were taken from the subjects after they had fasted overnight4 for measurement of total serum cholesterol concentration'4 and serum triglyceride concentration.'5 The women were weighed to the nearest 0 1 kg with a balance scale while they were wearing only briefs. Their height (without shoes) was measured to the nearest 0 5 cm, and their body mass index was calculated (weight (kg)/(height (m))2). A steel tape measure was used to measure the women's waist circumference, midway between the lower rib margin and the iliac crest, and hip circumference at the widest point between the iliac crest and buttock. The circumferences were measured in a standing position and to the nearest The lowest quarter was used as the reference with a relative risk of one. Increased relative risks in the highest quarter were more pronounced for serum triglyceride concentration and the ratio of waist circumference to hip circumference than for serum cholesterol concentration and body mass index. For all deaths, the relative risk increased for each successive quarter of waist:hip ratio and serum triglyceride concentration. For death from myocardial infarction, a smooth dose-response pattem was seen only for the waist:hip ratio. The risks for women in the highest quarter of each risk factor were compared with those of women in the lower three quarters (table III) . For all deaths and death from myocardial infarction, significantly increased relative risks were observed for serum triglyceride concentrations and waist:hip ratios. For serum cholesterol concentration and body mass index, significant associations were observed with respect to death from myocardial infarction only. To further examine the independent contributions of the four risk factors studied with respect to total mortality, the above analysis was repeated after stratifying the sample into two groups of 562 smokers and 811 non-smokers. Serum triglyceride concentration and waist:hip ratio were associated with increased risk of total mortality in both smokers (p=0 05 and 0-02 respectively) and non-smokers (p=0 004 and 0 001 respectively). These associations were independent of body mass index and serum cholesterof levels, which remained non-significant in both groups.
Discussion
Our study shows that increased serum triglyceride concentration and abdominal adiposity are associated with a sharply increased risk of both total mortality and death from myocardial infarction whereas an increased serum cholesterol concentration and increased general adiposity-expressed as body mass index-are much weaker risk factors. We stress our results conceming serum lipids as there has been much interest worldwide in elevated serum cholesterol concentration as a risk factor for cardiovascular disease. High serum cholesterol concentration is generally appreciated to be a risk factor in men, and determination of serum cholesterol concentration has been incorporated in many screening programmes. However, little attention has been given to the possibility that the risk profiles associated with serum lipids may be quite different in women. There is increasing evidence that increased serum triglyceride values are more predictive in the screening of women. One study comparing women in Gothenburg who had myocardial infarction with Clinical implications * It is often assumed that the risk factors associated with cardiovascular disease are the same in women as in men * In particular, all types of obesity and hypercholesterolaemia are assumed to increase cardiovascular risk * This 20 year study of Swedish women, however, showed that increased serum triglyceride concentration and abdominal adiposity were associated with sharply increased risks of death from myocardial infarction and from all causes * In contrast, increased serum cholesterol concentration and body mass index (an indicator of general adiposity) were much weaker risk factors * The different strengths of these risk factors should be taken into account when considering risk in women participants in our population study showed a strong association between serum triglyceride concentration and myocardial infarction but not between serum cholesterol concentration and myocardial infarction. 4 This observation was confirmed prospectively in our 12 year follow up study5: serum triglyceride concentration was significantly and independently correlated with the incidence of myocardial infarction, stroke, and overall death whereas serum cholesterol concentration was not predictive of any of these end points. Similar results have been observed in other studies (such as another cross sectional study in Gothenburg,6 the Stockholm prospective study,7 and the Framingham study8 9) while we are not aware of any study showing the opposite.
In many studies overall obesity-often expressed as an elevated body mass index-has not been significantly related to myocardial infarction17 18 or only in very large samples.'9 Our results show that the localisation of the adipose tissue is more important than the total amount of it. We found that an increased ratio of waist circumference to hip circumference was a significant risk factor for mortality from myocardial infarction and total mortality independent of body mass index whereas body mass index itself was not a significant independent risk factor. These results are consistent with those reported after our 12 year follow up. ' With respect to total mortality, we conducted several stratified tests in an attempt to identify particular groups at risk. The effect of elevated serum triglyceride concentrations was similar irrespective of whether serum cholesterol levels were low or high. The waist:hip ratio had a significant effect in combination with low and high body mass index. The effects of triglyceride concentration and waist:hip ratio were also present in both smokers and non-smokers. We hope that larger studies will be able to further address this question with special attention to mortality from myocardial infarction.
It is clear that the small number of end points may limit the statistical power for examination of several risk factors. However, our analysis suggests that serum triglyceride concentration and waist:hip ratio are strong independent risk factors for all deaths and death from myocardial infarction. The results from this study of women are of interest because they are based on a representative population sample, there was a high initial participation rate, and information could be obtained from 99% of the initial participants after 20 years. Objective-To investigate the role of genetically determined differences in the enzymes of alcohol metabolism in susceptibility to liver damage from misusing alcohol.
Design-Use of pADH36 probe to study PVU II restriction length fragment polymorphism in alcohol dehydrogenase 2 gene in white alcohol misusers and controls.
Setting-Teaching hospital referral centres for liver disease and alcohol misuse.
Subjects-45 white alcohol misusers (38 with alcoholic liver disease) and 23 healthy controls.
Main outcome measures-Alcohol misuse, the presence and severity of alcoholic liver disease, alcohol dependency, and family history of alcohol misuse.
Results-A two allele polymorphism (A and B) was identified. In control subjects the allele frequencies were 85% for A and 15% for B compared with 370/0 and 63% respectively in alcohol misusers (p < 0-001). B allele was significantly associated with severe liver damage (p<0.05) as well as alcohol dependency and family history of alcohol misuse compared with controls.
Conclusion 6 In addition, dependent alcoholics undergoing detoxification show alterations in ethanol metabolism compared with misusers without signs of dependency or control subjects.7 Acetaldehyde, the highly toxic product of ethanol metabolism, is thought to play an important part in alcohol induced liver damage and may also contribute to the pathogenesis of alcohol dependency.89 It is therefore likely that alcohol dehydrogenase, which accounts for over 90% of ethanol metabolism in the liver and determines the rate of acetaldehyde formation, is implicated in genetic susceptibility to alcoholic liver disease.
Alcohol dehydrogenase shows considerable polymorphism. It has more than 20 different isoenzymes with greatly differing kinetic properties in vitro.10'1 The enzyme is encoded by three gene loci, ADH1, ADH2, and ADH3, which lie adjacent to each other on chromosome 4. Polymorphism is present only at the ADH2 and ADH3 loci.'2 We investigated the association between a genetic marker-a two-allele restriction fragment length polymorphism in the gene ADH2-with historical features of alcoholic liver disease and clinical features of alcohol dependency in a white population.
Materials and methods
We studied 45 alcoholic patients and 23 nonalcoholic control subjects, all of whom were white. The patients were referrals to teaching hospital liver disease and alcohol misuse units, whereas the control subjects were research or laboratory staff recruited on a voluntary basis (table I) . Although the average age of the controls was younger (mean 36 v 52 years), most of the alcohol misusers had established drinking habits by their mid-30s. All of the controls drank less than an average of 24 g of ethanol daily. All patients had consumed at least 80 g of ethanol daily (mean 146 (SE 9 8) g/day) for a minimum of two (mean 13 6 (1 8) years) and had come to medical attention because of the direct consequences of their alcohol misuse. Twenty one of the 45 patients showed clinical features of, and satisfied questionnaire criteria for, alcohol dependency and 19 had a family history of alcoholism, with at least one affected first degree relative.
Thirteen patients were referred for either detoxification or treatment of alcohol misuse, and 32 for treatment of acute alcoholic hepatitis or complications of cirrhosis (bleeding oesophageal varices, ascites, or
